Michael J Fox Foundation for Parkinson’s Research:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Michael J Fox Foundation for Parkinson's Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9340
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Michael J Fox Foundation for Parkinson’s Research (Michael J. Fox) is a research foundation that conducts research on Parkinson’s disease. The foundation offers research and development of therapies. It provides drug development and other research activities. Michael J. Fox offers treatments which include deep brain stimulation, medication and therapy development. The foundation operates through drug development service companies, pharmaceuticals and healthcare centers. It collaborates with other companies to enhance its research programs through funding, in-kind contributions, strategic input, and others. Michael J. Fox is headquartered in New York, the US.

Michael J Fox Foundation for Parkinson’s Research – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Michael J Fox Foundation for Parkinson’s Research, Medical Devices Deals, 2012 to YTD 2018 9
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Michael J Fox Foundation for Parkinson’s Research, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
MJFF Acquires Research Tools from Imago Pharma 11
Partnerships 12
ViGene Enters into Agreement with Michael J. Fox 12
Michael J. Fox Foundation Plans to Enter into Co-Development Agreement with Van Andel Research Institute and Cure Parkinson’s Trust 13
Charles River Labs Expands Agreement with Michael J. Fox Foundation for Parkinson’s Research 14
MJFF Enters into Agreement with Prothena 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 17
Merger 18
Michael J. Fox Foundation and Michael Stern Parkinson’s Research Foundation Merge 18
Michael J Fox Foundation for Parkinson’s Research – Key Competitors 19
Michael J Fox Foundation for Parkinson’s Research – Key Employees 20
Michael J Fox Foundation for Parkinson’s Research – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Apr 19, 2017: The Michael J. Fox Foundation Promotes Sohini Chowdhury to Deputy Chief Executive Officer 23
Government and Public Interest 24
Apr 11, 2018: Portfolio company Mission Therapeutics awarded research grant from the Michael J Fox Foundation 24
Oct 03, 2017: AC Immune Awarded Continuation of 2015 Grant from The Michael J. Fox Foundation for Parkinsons Research 25
May 20, 2017: Wim Versees receives Michael J. Fox Foundation grant for investigating Parkinson’s disease-associated protein 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Key Facts 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Michael J Fox Foundation for Parkinson's Research, Deals By Therapy Area, 2012 to YTD 2018 8
Michael J Fox Foundation for Parkinson's Research, Medical Devices Deals, 2012 to YTD 2018 9
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MJFF Acquires Research Tools from Imago Pharma 11
ViGene Enters into Agreement with Michael J. Fox 12
Michael J. Fox Foundation Plans to Enter into Co-Development Agreement with Van Andel Research Institute and Cure Parkinson's Trust 13
Charles River Labs Expands Agreement with Michael J. Fox Foundation for Parkinson’s Research 14
MJFF Enters into Agreement with Prothena 15
MJFF, Jefferson And Taconic Enter Into Co-Development Agreement 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 17
Michael J. Fox Foundation and Michael Stern Parkinson's Research Foundation Merge 18
Michael J Fox Foundation for Parkinson's Research, Key Competitors 19
Michael J Fox Foundation for Parkinson's Research, Key Employees 20

List of Figures
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Michael J Fox Foundation for Parkinson's Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Michael J Fox Foundation for Parkinson's Research, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Michael J Fox Foundation for Parkinson’s Research:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Textron Systems Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Textron Systems Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Chennai Petroleum Corp Ltd (CHENNPETRO):企業の財務・戦略的SWOT分析
    Chennai Petroleum Corp Ltd (CHENNPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Noble Corporation plc:企業の戦略・SWOT・財務分析
    Noble Corporation plc - Strategy, SWOT and Corporate Finance Report Summary Noble Corporation plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Gr. Sarantis S.A. (SAR):企業の財務・戦略的SWOT分析
    Gr. Sarantis S.A. (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Nippon Soda Co., Ltd.:企業の戦略・SWOT・財務分析
    Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • IDT Biologika GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary IDT Biologika GmbH (IDT Biologika), a subsidiary of Klocke Pharma-Service GmbH, is a vaccines and pharmaceuticals manufacturer. The company offers contract manufacturing services. It provides integrated development and manufacturing services in four major areas of animal health, vaccines, ph …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • STP&I Public Company Limited:企業の戦略・SWOT・財務情報
    STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Antibe Therapeutics Inc (ATE):企業の財務・戦略的SWOT分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • CITIC Pacific Limited:企業のM&A・事業提携・投資動向
    CITIC Pacific Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CITIC Pacific Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Reliance Industries Ltd (RELIANCE):企業の財務・戦略的SWOT分析
    Reliance Industries Ltd (RELIANCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • WGL Holdings Inc (WGL)-石油・ガス分野:企業M&A・提携分析
    Summary WGL Holdings, Inc. (WGL) is an energy holding company that delivers natural gas, and provides energy-related products and services to customers. It also provides design-build energy efficient and sustainable solutions and water and energy-related infrastructure services. The company delivers …
  • Sembcorp Industries Ltd (U96)-エネルギー分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Apache Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Apache Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Apache Corp (Apache) is an independent upstream energy company, which carries out exploration, development and production of natural gas, crude oil and natural gas liquids (NGLs). It has onshore and offs …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆